AMUNDI ASSET MANAGEMENT US, INC. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMUNDI ASSET MANAGEMENT US, INC. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2021$4,682,000
+5.9%
42,174
+13.3%
0.00%0.0%
Q4 2020$4,421,000
+55.9%
37,233
+14.5%
0.00%
+33.3%
Q3 2020$2,835,000
+23.5%
32,504
+26.8%
0.00%0.0%
Q2 2020$2,296,000
-2.2%
25,643
+8.8%
0.00%
-25.0%
Q1 2020$2,347,000
-39.6%
23,559
-30.3%
0.00%
-20.0%
Q4 2019$3,883,000
+25.7%
33,797
+38.0%
0.01%0.0%
Q3 2019$3,090,000
+377.6%
24,499
+231.5%
0.01%
+400.0%
Q1 2019$647,000
-12.4%
7,3910.0%0.00%0.0%
Q4 2018$739,000
+234.4%
7,391
+283.9%
0.00%
Q3 2018$221,000
-95.9%
1,925
-98.5%
0.00%
-100.0%
Q4 2012$5,378,000131,6800.02%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders